Hidradenitis suppurativa, eruptive melanocytic nevi, and keratosis pilaris-like eruption in a patient treated with vemurafenib

Archives of Dermatology

Volumn 148, Issue 12, 2012, Pages 1428-1429

  Ma, Liqiao ^a   Dominguez, Arturo R ^a   Collins, George R ^a   Kia, Kevin F ^a   Cockerell, Clay J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; CARBOPLATIN; DOXYCYCLINE; PACLITAXEL; RETINOIC ACID; TEMOZOLOMIDE; VEMURAFENIB;

ADULT; ARTICLE; BRAIN METASTASIS; CASE REPORT; DARIER DISEASE; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MELANOCYTIC NEVUS; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKIN BIOPSY; SUPPURATIVE HIDRADENITIS;

DRUG ERUPTIONS; HIDRADENITIS SUPPURATIVA; HUMANS; INDOLES; KERATOSIS; MALE; MELANOMA; MIDDLE AGED; NEVUS, PIGMENTED; PROTEIN KINASE INHIBITORS; SKIN NEOPLASMS; SULFONAMIDES;

EID: 84871367383     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/2013.jamadermatol.23     Document Type: Article

References (5)

1. Huang V, Hepper D, Anadkat M, Cornelius L. Cutaneous toxic effects associated with vemurafenib and inhibition of the BRAF pathway. Arch Dermatol. 2012;148(5):628-633.
2. Zimmer L, Hillen U, Livingstone E, et al. Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition. J Clin Oncol. 2012;30(19):2375-2383.
3. Kong HH, Sibaud V, Chanco Turner ML, Fojo T, Hornyak TJ, Chevreau C. Sorafenib-induced eruptive melanocytic lesions. Arch Dermatol. 2008;144(6):820-822. (Pubitemid 351846901)
4. Sekulic A, Colgan MB, Davis MD, DiCaudo DJ, Pittelkow MR. Activating BRAF mutations in eruptive melanocytic naevi. Br J Dermatol. 2010;163(5):1095-1098.
5. Breit S, Flaig MJ, Wolff H, Plewig G. Favre-Racouchot-like disease after radiation therapy. J Am Acad Dermatol. 2003;49(1):117-119. (Pubitemid 36801645)